SciELO - Scientific Electronic Library Online

 
vol.111 número6HIV and SARS-CoV-2 co-infection: The diagnostic challenges of dual pandemics índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

    Links relacionados

    • En proceso de indezaciónCitado por Google
    • En proceso de indezaciónSimilares en Google

    Compartir


    SAMJ: South African Medical Journal

    versión On-line ISSN 2078-5135versión impresa ISSN 0256-9574

    Resumen

    ZAMPARINI, J et al. Considerations for COVID-19 vaccination in pregnancy. SAMJ, S. Afr. med. j. [online]. 2021, vol.111, n.6, pp.544-549. ISSN 2078-5135.  https://doi.org/10.7196/SAMJ.2021.v111i6.15660.

    Pregnant women are at greater risk of severe COVID-19 than non-pregnant women. Despite limited safety data on use of COVID-19 vaccines in pregnancy, many international societies have recommended their use when pregnant women are at particularly high risk of acquiring COVID-19, or have suggested that vaccines should not be withheld from pregnant women where no other contraindications to COVID-19 vaccination exist. A number of vaccines, including those against influenza, tetanus and pertussis, have been shown to reduce both maternal and infant morbidity and mortality when used antenatally. We explore the role of COVID-19 vaccination in the setting of pregnancy, discuss the limited data available, and summarise current international guidelines.

            · texto en Inglés     · Inglés ( pdf )